Amgen Replaces Two Top Executives, Beats Quarterly Estimates

(Bloomberg) -- Amgen Inc. shook up its C-suite on Thursday with two major changes as the biotechnology company searches for new therapies to replace fading blockbusters facing strong competition.

Bloomberg Quint

Add BloombergQuint App to Home screen.